These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21651006)

  • 1. Unraveling cancer risk with cellular and molecular tools.
    Patlak M
    Environ Sci Technol; 1998 Jul; 32(13):312A-6A. PubMed ID: 21651006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in molecular labeling, high throughput imaging and machine intelligence portend powerful functional cellular biochemistry tools.
    Price JH; Goodacre A; Hahn K; Hodgson L; Hunter EA; Krajewski S; Murphy RF; Rabinovich A; Reed JC; Heynen S
    J Cell Biochem Suppl; 2002; 39():194-210. PubMed ID: 12552619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking and lung cancer: future research directions.
    Haussmann HJ
    Int J Toxicol; 2007; 26(4):353-64. PubMed ID: 17661227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the incorporation of chemical-specific information in risk assessment.
    Clewell HJ; Andersen ME; Blaauboer BJ
    Toxicol Lett; 2008 Aug; 180(2):100-9. PubMed ID: 18588959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New directions in incidence-dose modeling.
    Andersen ME; Dennison JE; Thomas RS; Conolly RB
    Trends Biotechnol; 2005 Mar; 23(3):122-7. PubMed ID: 15734554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of clinical trials in unraveling the mysteries of multiple sclerosis.
    McFarland H
    J Neuroimmunol; 2011 Feb; 231(1-2):3-6. PubMed ID: 21300410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding mechanisms of toxicity: insights from drug discovery research.
    Houck KA; Kavlock RJ
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the ecological risk assessment process.
    Dale VH; Biddinger GR; Newman MC; Oris JT; Suter GW; Thompson T; Armitage TM; Meyer JL; Allen-King RM; Burton GA; Chapman PM; Conquest LL; Fernandez IJ; Landis WG; Master LL; Mitsch WJ; Mueller TC; Rabeni CF; Rodewald AD; Sanders JG; van Heerden IL
    Integr Environ Assess Manag; 2008 Jul; 4(3):306-13. PubMed ID: 18324871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the need for restricting the probabilistic analysis in risk assessments to variability.
    Aven T
    Risk Anal; 2010 Mar; 30(3):354-60; author reply 381-4. PubMed ID: 19919552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatially explicit ecological exposure models: a rationale for and path toward their increased acceptance and use.
    Wickwire T; Johnson MS; Hope BK; Greenberg MS
    Integr Environ Assess Manag; 2011 Apr; 7(2):158-68. PubMed ID: 21442731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals in the environment: lessons learned for reducing uncertainties in environmental risk assessment.
    Brooks BW; Berninger JP; Kristofco LA; Ramirez AJ; Stanley JK; Valenti TW
    Prog Mol Biol Transl Sci; 2012; 112():231-58. PubMed ID: 22974742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of manic depressive illness: current status and evolving concepts.
    Baron M
    Res Publ Assoc Res Nerv Ment Dis; 1991; 69():153-64. PubMed ID: 2003158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On different types of uncertainties in the context of the precautionary principle.
    Aven T
    Risk Anal; 2011 Oct; 31(10):1515-25. PubMed ID: 21477085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical models for probabilistic dose-response assessment.
    Kodell RL; Chen JJ; Delongchamp RR; Young JF
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):265-72. PubMed ID: 16769166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of quantitative risk assessments for characterizing risk and uncertainty and delineating appropriate risk management options, with special emphasis on terrorism risk.
    Aven T; Renn O
    Risk Anal; 2009 Apr; 29(4):587-600. PubMed ID: 19144065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations.
    Spiegel K; Magistrato A
    Org Biomol Chem; 2006 Jul; 4(13):2507-17. PubMed ID: 16791311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights aid computational short interfering RNA design.
    Boese Q; Leake D; Reynolds A; Read S; Scaringe SA; Marshall WS; Khvorova A
    Methods Enzymol; 2005; 392():73-96. PubMed ID: 15644176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.